EP0525720B1 — Inhalation devices
Assigned to New England Pharmaceuticals Inc · Expires 1996-12-18 · 29y expired
What this patent protects
An oral or nasal inhalation device comprises an air passageway (22) optionally shaped as a venturi passing through a body (20). A holder (40) on the body receives a single dose powder container (60) containing a medicament. A piercer (26) or needle having a bore therethrough exte…
USPTO Abstract
An oral or nasal inhalation device comprises an air passageway (22) optionally shaped as a venturi passing through a body (20). A holder (40) on the body receives a single dose powder container (60) containing a medicament. A piercer (26) or needle having a bore therethrough extends from the body into the holder. The user places the container and removes a seal on the top end of the container. Alternatively, the piercer is longer than the container and pierces both ends of it, obviating the need for a removable seal (62). A sharp inhalation causes air to be drawn through the air intake (27), creating a partial vacuum in the air passageway and causing the powder to be dispensed from the container through the bore of the piercer. Another embodiment has two piercers, each acting on an end of the container. Further embodiments make use of a rotable disk provided with multiple containers. <IMAGE>
Drugs covered by this patent
- Lignospan Forte (Lidocaine Hydrochloride) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.